3 Reasons Intercept Pharma Could Surge 180%
September 20, 2017 at 15:22 PM EDT
Bernstein’s Michael Yee says this battered drug maker could skyrocket to $275 a share. Here’s why.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.